TOKYO - AstraZeneca Plc plans to produce over 90 million COVID-19 vaccine doses in Japan, or about 75 percent of what the country is set to receive from the British pharmaceutical firm, the top government spokesman said Thursday.
Sorry. This article is no longer available.
Sorry, this article was first published more than three months ago and is temporarily unavailable.
Once the upcoming introduction of a paid membership system is fully operational, paid members will have access to all our stories.
Free Membership Provides
Newsletter from Editorial Team and access to archive articles from past three months.
By continuing, you agree to the Terms of Use,
and Privacy Policy.
